Soleno Therapeutics Historical PE Ratio image   This SLNO PE ratio history page last updated 3/21/2024
Soleno Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/6/2024
46.38-0.33-1.32NA
Q3 2023
11/7/2023
23.00-0.95-3.80NA
Q2 2023
8/8/2023
5.13-0.81-3.24NA
Q1 2023
5/9/2023
4.32-0.88-3.52NA
Q4 2022
3/21/2023
2.14-0.58-2.32NA
Q3 2022
11/9/2022
0.92-0.76-3.04NA
Q2 2022
8/10/2022
2.67-0.90-3.60NA
Q1 2022
5/10/2022
2.28-1.05-4.20NA
Q4 2021
3/31/2022
3.35-0.60-2.40NA
Q3 2021
11/10/2021
11.43-1.50-6.00NA
Q2 2021
7/28/2021
13.82-2.10-8.40NA
Q1 2021
5/5/2021
16.95-1.65-6.60NA
Q4 2020
3/3/2021
39.75-0.60-2.40NA
Q3 2020
11/10/2020
30.15-1.65-6.60NA
Q2 2020
8/10/2020
28.20-2.40-9.60NA
Q1 2020
5/12/2020
49.50-1.95-7.80NA
Q4 2019
3/4/2020
49.20-5.40-21.60NA
Q3 2019
11/13/2019
23.100.451.8012.8
Q2 2019
8/7/2019
29.85-4.65-18.60NA
Q1 2019
5/13/2019
30.00-3.30-13.20NA
Q4 2018
3/18/2019
38.700.301.2032.3
Q3 2018
11/15/2018
30.60-1.65-6.60NA
Q2 2018
8/14/2018
39.86-5.40-21.60NA
Q1 2018
5/16/2018
26.25-2.55-10.20NA
Q4 2017
4/2/2018
26.25-5.85-23.40NA
Q3 2017
11/14/2017
27.30-3.60-14.40NA
Q2 2017
8/11/2017
30.00-4.50-18.00NA
Q1 2017
5/11/2017
52.50-8.25-33.00NA
Q4 2016
3/15/2017
56.25-12.00-48.00NA
Q3 2016
11/14/2016
73.50-30.75-123.00NA
Q2 2016
8/12/2016
71.70-17.25-69.00NA
Q1 2016
5/10/2016
88.50-16.50-66.00NA
Q4 2015
3/24/2016
96.75-16.50-66.00NA
Q3 2015
11/12/2015
141.75-24.75-99.00NA
Q2 2015
8/7/2015
153.7518.7575.002.0
Q1 2015
5/4/2015
426.00-125.25-501.00NA
Q4 2014
3/10/2015
415.50-167.25-669.00NA
Q3 2014
12/18/2014
124.50-335.25-1341.00NA
Soleno Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/6/2024
46.38-0.33-2.97NA
Q3 2023
11/7/2023
23.00-0.95-3.22NA
Q2 2023
8/8/2023
5.13-0.81-3.03NA
Q1 2023
5/9/2023
4.32-0.88-3.12NA
Q4 2022
3/21/2023
2.14-0.58-3.29NA
Q3 2022
11/9/2022
0.92-0.76-3.31NA
Q2 2022
8/10/2022
2.67-0.90-4.05NA
Q1 2022
5/10/2022
2.28-1.05-5.25NA
Q4 2021
3/31/2022
3.35-0.60-5.85NA
Q3 2021
11/10/2021
11.43-1.50-5.85NA
Q2 2021
7/28/2021
13.82-2.10-6.00NA
Q1 2021
5/5/2021
16.95-1.65-6.30NA
Q4 2020
3/3/2021
39.75-0.60-6.60NA
Q3 2020
11/10/2020
30.15-1.65-11.40NA
Q2 2020
8/10/2020
28.20-2.40-9.30NA
Q1 2020
5/12/2020
49.50-1.95-11.55NA
Q4 2019
3/4/2020
49.20-5.40-12.90NA
Q3 2019
11/13/2019
23.100.45-7.20NA
Q2 2019
8/7/2019
29.85-4.65-9.30NA
Q1 2019
5/13/2019
30.00-3.30-10.05NA
Q4 2018
3/18/2019
38.700.30-9.30NA
Q3 2018
11/15/2018
30.60-1.65-15.45NA
Q2 2018
8/14/2018
39.86-5.40-17.40NA
Q1 2018
5/16/2018
26.25-2.55-16.50NA
Q4 2017
4/2/2018
26.25-5.85-22.20NA
Q3 2017
11/14/2017
27.30-3.60-28.35NA
Q2 2017
8/11/2017
30.00-4.50-55.50NA
Q1 2017
5/11/2017
52.50-8.25-68.25NA
Q4 2016
3/15/2017
56.25-12.00-76.50NA
Q3 2016
11/14/2016
73.50-30.75-81.00NA
Q2 2016
8/12/2016
71.70-17.25-75.00NA
Q1 2016
5/10/2016
88.50-16.50-39.00NA
Q4 2015
3/24/2016
96.75-16.50-147.75NA
Q3 2015
11/12/2015
141.75-24.75-298.50NA
Q2 2015
8/7/2015
153.7518.75-609.00NA
Q1 2015
5/4/2015
426.00-125.25NANA
Q4 2014
3/10/2015
415.50-167.25NANA
Q3 2014
12/18/2014
124.50-335.25NANA
Quotes delayed 20 minutes

Email EnvelopeFree SLNO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Soleno Therapeutics (SLNO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SLRN PE Ratio History
SLRX PE Ratio History
SLS PE Ratio History
SMLR PE Ratio History
SMMT PE Ratio History
SMTI PE Ratio History
SNDA PE Ratio History
SNDX PE Ratio History
SNGX PE Ratio History
SNOA PE Ratio History
How should the SLNO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Soleno Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SLNO Historical PE Ratio page.

What is the average historical PE for SLNO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SLNO historical PE ratio using the annualized quarterly earnings method works out to 15.7.

What is the average historical PE for SLNO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SLNO historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Soleno Therapeutics Historical PE Ratio information for Soleno Therapeutics' stock. The average SLNO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 15.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SLNO historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SLNO historical PE result, against the recent PE: when this page was posted on 3/20/2024, the most recent closing price for SLNO had been 44.00, and the most recent quarterly earnings result, annualized, was 1.8. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent SLNO PE on 3/20/2024 based on annualized quarterly EPS was 24.4. Based on SLNO's history, that recent PE is elevated relative to the historical average, with the recent PE 55.4% higher than the historical average PE across our data set for Soleno Therapeutics.

For self directed investors doing their due diligence on SLNO or any other given stock, valuation analysis for SLNO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Soleno Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SLNO. Thanks for visiting, and the next time you need to research SLNO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: OLLI Historical Earnings, NPK Insider Buying, OBAF Historical Stock Prices.

 

Soleno Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.